Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects
- Status
- TERMINATED
- Phase
- PHASE3
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.088: NANT Pancreatic Cancer Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2